Eccentric treadmill training and skeletal muscle immunometabolic responses in HFD-induced insulin resistance

Read full text
Authors: Wei Luo, Yuanyuan Wang, Siyi He, Shijin Zhao, Yue Zhou, Lei Ai
Cited by: 1
References: 53

Abstract

Introduction In recent years, repeated eccentric exercise has gained increasing attention as a potentially superior intervention for ameliorating insulin resistance (IR). However, the underlying mechanisms responsible for these effects remain incompletely understood. This study aims to investigate the effects and underlying mechanisms of moderate-intensity eccentric treadmill training on skeletal muscle IR. Methods A mouse model of IR was established using a high-fat diet (HFD) for 12 weeks, followed by an 8-week eccentric treadmill training. In vitro , RAW264.7 macrophages under high-glucose conditions were treated with the AKT agonist SC79 or inhibitor MK2206. Comprehensive assessments included protein localization and expression (immunofluorescence, Western blot), macrophage polarization status (flow cytometry), inflammatory infiltration (H&E staining), cytokine profiles (ELISA), and cellular viability (CCK-8). Results HFD-induced IR led to elevated pro-inflammatory factors and reduced GLUT4, F4/80 & phospho-AKT (Ser 473 ) co-localization, IL-10, and Arg-1 levels, all of which were significantly reversed by eccentric training. In vitro , high glucose reduced the phospho-AKT (Ser 473 )/AKT ratio, while SC79 suppressed an M1-like pro- inflammatory phenotype, as indicated by decreased iNOS and F4/80&CD86 double-positive rates and increased Arg-1 and F4/80&CD206 double-positive rates. These effects were abolished by MK2206. Conclusion Moderate-intensity eccentric treadmill training ameliorates HFD-induced skeletal muscle IR, likely driven by AKT-mediated reduction in pro-inflammatory M1 macrophage polarization.

Fields of Study & Subjects

Exercise and Physiological Responses Adipokines Inflammation and Metabolic Diseases Adipose Tissue and Metabolism

Publication details

Journal / source
Frontiers in Immunology
Publisher
Frontiers Media SA
Volume
17
Pages
1757925–1757925
Publication date
25 February 2026
Language
EN